Within integrated swine production systems, gilt estrus synchronization for batch farrowing is achieved by oral administration of a veterinary API powder that is incorporated into non-sterile premixes, granules, or top-dress formulations at the feed mill or a licensed veterinary compounding facility. EU Regulation 2019/6 governs the veterinary medicinal product authorization, while medicated feed containing the finished premix falls under EU Regulation 2019/4; sampling and identity verification of the blended premix conform to ISO 6497:2002. The addition ratio of Cuiqing Powder Veterinary Grade API in the final premix is 0.20–0.50 wt% active dry powder, prepared by geometric dilution from an intermediate blend containing 5.0–10.0 wt% API on a lactose monohydrate or calcium carbonate carrier; final feed inclusion is adjusted from 1.0–5.0 kg per tonne to deliver the species-specific target dose. Production-scale batch records show that carrier particle size mismatch is a critical source of segregation when the API D90 is below 150 µm and the carrier D50 exceeds 300 µm; a two-stage blending process using a 0.3 m³ twin-shell V-blender or horizontal ribbon mixer with pre-blend time of 12 minutes and final blend time of 8 minutes is used to reach blend uniformity CV ≤ 5.0%. Carrier moisture is maintained below 10.0% to prevent caking during extended storage; if ambient RH exceeds 60%, the carrier is pre-dried in a fluid-bed dryer to ≤ 8.0% moisture before charging. Downstream processing for granule products uses dry granulation through a roller compactor with nip gap 1.0–2.0 mm and screen milling through a 1.0 mm aperture; the resulting granules are packed into polyethylene-lined multi-wall paper bags or 25 kg sacks. Terminal finished product types include medicated premix, oral granules, top-dress sachets, and pelleted feed concentrates for swine breeder operations.

What Dry-Blend Uniformity Limits Apply to Ovine Oral Tablets?

Compression of low-dose Cuiqing Powder Veterinary Grade API into small-diameter oral tablets for sheep and goats requires both acceptable content uniformity and rapid disintegration in the rumen or abomasum. The granulation batch is formulated with an API addition ratio of 0.8–2.5 wt% in the core blend; the diluent matrix comprises spray-dried lactose monohydrate and dibasic calcium phosphate dihydrate at a 3:1 ratio, crospovidone at 3.0–5.0 wt%, and magnesium stearate at 0.5–1.0 wt% added in final lubrication. Compliance testing follows Ph. Eur. 2.9.5 for uniformity of mass, USP <905> for uniformity of dosage units, Ph. Eur. 2.9.3 and USP <701> for disintegration, and Ph. Eur. 2.9.7 for friability. Wet granulation is performed in a high-shear granulator with impeller tip speed 4–6 m/s and binder spray rate 0.5–1.0 kg/min; the wet mass is dried in a fluid-bed dryer at inlet air 60–70°C to a loss-on-drying endpoint of 1.5–2.5%. The dried granules are milled through a 0.8 mm conical screen. Compression of 6–10 mm round concave tooling is run at 8–15 kN compression force; tablet hardness is held at 50–90 N. Over-lubrication is avoided because magnesium stearate blending beyond 5 minutes reduces tablet crushing strength and slows dissolution in 0.1 N HCl at 37°C. Terminal finished product types include 10–50 mg oral tablets, scored tablets for dose titration, and rapidly dispersing tablets for veterinary oral administration in ovine and caprine reproduction programs.

Terminal moist-heat sterilization and the limits of bovine injectable solution manufacture

If a multi-dose injectable solution for cattle is specified, the formulation strategy must resolve the conflict between terminal sterilization thermal load and the heat sensitivity of the API powder in aqueous media. The addition ratio of Cuiqing Powder Veterinary Grade API in the finished injection is 0.10–0.30 wt%, dissolved in Water for Injection with benzyl alcohol at 1.0–1.5 wt% as preservative for multi-dose vials; the pH is adjusted to 4.5–6.0 with citrate buffer, and the solution is sparged with nitrogen to reduce oxidative degradation. Compliance testing for sterility follows Ph. Eur. 5.1.1 and USP <71>; bacterial endotoxin limits are assessed by Ph. Eur. 2.6.14 and USP <85>; sub-visible particulate matter is controlled by Ph. Eur. 2.9.19 and USP <788>. Production-scale filling lines must decide between terminal moist-heat sterilization at 121°C for 15 minutes and aseptic filtration through a 0.22 µm PVDF membrane when the API shows thermal degradation above 80°C. Published data for this specific API configuration is limited, so thermal challenge studies at 118–124°C with kill-rate bracketing are required before terminal sterilization is adopted. Aseptic fill trials on a 100-vial/min peristaltic filling line use pre-sterilized silicone tubing, sterile-grade filters, and 100 mL amber Type II glass vials with chlorobutyl rubber stoppers; closure integrity is confirmed by dye ingress per USP <1207>. Terminal finished product types include 50 mL, 100 mL, and 250 mL multi-dose injectable solutions for bovine reproductive management, with a product temperature control limit of ≤ 25°C during filling.

Batch records from equine compounding operations show that oral top-dress powders and granules require an additional wettability step when the API powder is hydrophobic or electrostatically charged. Cuiqing Powder Veterinary Grade API is incorporated into a fluid-bed granulated carrier at 1.0–5.0 wt% of the final dry granule mass; the carrier consists of maltodextrin or sucrose with 2.0–4.0 wt% purified water or hypromellose solution as binder. Compliance for the finished oral granule is based on EU Regulation 2019/6 for marketing authorization and VICH GL18 for residual solvent and impurity assessment; particle size distribution is verified by laser diffraction according to ISO 13320:2020, and loss on drying is checked by Ph. Eur. 2.2.32. The fluid-bed processor is operated in top-spray mode with inlet air 55–65°C, product temperature 30–40°C, atomization air pressure 1.5–2.5 bar, and spray rate 10–30 mL/min for a 5 kg batch; the granulate is screened through a 1.0 mm sieve and packaged only when residual moisture is ≤ 3.0%. If ambient RH exceeds 60%, the finished granules are filled into HDPE containers with desiccant packets because the API-containing granule surface becomes hygroscopic and flowability drops sharply. The terminal finished product types include 250 g, 500 g, and 1 kg HDPE containers of oral top-dress powder or granules for horse breeding management under veterinary prescription.

Capsule filling lines and low-dose API segregation control for managed breeding of out-of-season small ruminants

Capsule filling lines producing low-dose small-ruminant reproductive capsules exhibit electrostatic charging of the milled API powder on gelatin or HPMC shells, creating weight variation that cannot be corrected by machine adjustment alone. The addition ratio of Cuiqing Powder Veterinary Grade API is kept at 0.5–2.0 wt% of the powder fill mass; the base filler is lactose monohydrate with a D50 near 100 µm, and colloidal silicon dioxide is added at 0.25 wt% to reduce interparticle cohesion. Compliance for single-dose uniformity is tested by Ph. Eur. 2.9.6 and USP <905>, capsule disintegration by Ph. Eur. 2.9.1 and USP <701>, and dissolution by USP <711> where a monograph exists. The capsule filling machine is configured with dosator or tamping pin units; the powder hopper is maintained at 40–50% RH and 20–25°C to avoid static charge accumulation. Filling speed is limited to 30,000 capsules/h when the API is in the sub-50 µm particle size range because higher speeds increase fill weight relative standard deviation above 3.0%. After filling, capsules are passed through a metal detector and a weight sorter rejecting deviations above ±5% of target fill weight. Terminal finished product types include size 3 and 4 hard capsules containing 200–500 mg powder fill for oral administration in ovine, caprine, and exotic small ruminant breeding programs.

In veterinary clinics with large-animal ambulatory services, water-soluble powders intended for oral solution or stomach-tube drenching are prepared by blending the API powder with buffer salts and sweeteners before sachet filling. The addition ratio of Cuiqing Powder Veterinary Grade API is 2.0–8.0 wt% of the sachet fill mass; the excipient matrix contains sodium citrate dihydrate at 50–70 wt%, sorbitol at 15–25 wt%, and colloidal silicon dioxide at 0.5 wt% to maintain flow. Compliance for the non-sterile powder follows EU Regulation 2019/6 and 21 CFR Part 211 for current good manufacturing practice; solution clarity and redispersion are tested using Ph. Eur. 2.9.1 where a monograph exists. The powder blend is prepared in a 300 L tumble blender at 12 rpm for 20 minutes, passed through a 0.5 mm sieve, and filled into heat-sealed foil-laminate sachets at 40% RH or lower. Dissolution of the finished powder in water at 25°C reaches complete dispersion within 90 seconds under gentle stirring; if water hardness exceeds 300 mg/L CaCO₃, citrate buffer content is increased to prevent precipitation. Terminal finished product types include 5 g, 10 g, and 20 g single-dose sachets for oral solution or stomach-tube drenching in cattle and horses.